Mark Horrigan

Reperfusion Times and Outcomes in Patients With ST-Elevation Myocardial Infarction Presenting Without Pre-Hospital Notification.

Garry W Hamilton, Julian Yeoh, Diem Dinh, Angela Brennan, Matias B Yudi, Melanie Freeman, Mark Horrigan, Lorelle Martin, Christopher M Reid, Thomas Yip, Sandra Picardo, Anand Sharma, Stephen J Duffy, Omar Farouque, David J Clark, Andrew E Ajani, undefined Melbourne Interventional Group

Journal article  |  2022  |  Cardiovasc Revasc Med

BACKGROUND: Primary percutaneous coronary intervention (PCI) for patients with ST-elevation myocardial infarction (STEMI) is recom..

Safety and Long-Term Clinical Outcomes of Fractional Flow Reserve Guided Coronary Revascularisation

Timothy G Scully, Liam Toner, Julian Yeoh, Omar Farouque, Matias B Yudi, Mark Horrigan, David J Clark

Journal article  |  2021  |  HEART LUNG AND CIRCULATION

BACKGROUND: Increasingly, fractional flow reserve (FFR) is employed to assess coronary artery stenoses although there is limited r..

Postoperative Atrial Fibrillation and Long-Term Risk of Stroke in Patients Undergoing Liver Transplantation

Anoop N Koshy, Anees Enyati, Laurence Weinberg, Hui-Chen Han, Mark Horrigan, Paul J Gow, Jefferson Ko, Vincent Thijs, Adam Testro, Han S Lim, Omar Farouque, Andrew W Teh

Journal article  |  2021  |  STROKE

BACKGROUND AND PURPOSE: Postoperative atrial fibrillation (POAF) is the commonest cardiovascular complication following liver tran..

Feasibility and Safety of Drug-Eluting Stent Implantation in Patients with End-Stage Liver Disease Prior to Liver Transplantation

Rodrigues T Sampaio, A Koshy, P Gow, D Clark, M Horrigan, O Farouque

Journal article  |  2021  |  Heart, Lung and Circulation

Plasma desmosine, a biomarker of elastin degradation, predicts outcomes in coronary artery disease

Z Iskandar, S Patel, T Lancefield, M Freeman, M Horrigan, O Farouque, JTJ Huang, CC Lang, LM Burrell, AM Choy

Conference Proceedings  |  2020  |  EUROPEAN HEART JOURNAL

Abstract Background Recent evidence from animal studies suggests that elastin ..

Long-Term Results of the RAPCO Trials

Brian F Buxton, Philip A Hayward, Jai Raman, Simon C Moten, Alexander Rosalion, Ian Gordon, Siven Seevanayagam, George Matalanis, Umberto Benedetto, Mario Gaudino, David L Hare

Journal article  |  2020  |  CIRCULATION

BACKGROUND: An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but c..

Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

Anoop N Koshy, Alexandra Murphy, Omar Farouque, Mark Horrigan, Matias B Yudi

Journal article  |  2020  |  HEART LUNG AND CIRCULATION

BACKGROUND: Transcatheter aortic valve replacement (TAVR) has revolutionised the treatment of severe aortic stenosis (AS), though ..

Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges

James Anderson, Melanie Lavender, Edmund Lau, David Celermajer, Nicholas Collins, Nathan Dwyer, John Feenstra, Mark Horrigan, Dominic Keating, Anne Keogh, Eugene Kotlyar, Benjamin Ng, Susanna Proudman, Peter Steele, Vivek Thakkar, Robert Weintraub, Helen Whitford, Trevor Williams, Jeremy Wrobel, Geoff Strange

Journal article  |  2020  |  HEART LUNG AND CIRCULATION

BACKGROUND: Combination drug therapy for pulmonary arterial hypertension (PAH) is the international standard of care for most pati..

Assessment of Cardiac Function in Chemotherapy Naive Women With Breast Cancer Undergoing Contemporary Radiation Therapy

Alexandra C Murphy, Terase F Lancefield, Michael Chao, Farshad Foroudi, Anoop N Koshy, Simon Undrill, Mark Horrigan, Belinda Yeo, Matias B Yudi, Leighton Kearney, Omar Farouque

Journal article  |  2020  |  JACC: CARDIOONCOLOGY

Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes

Alexandra C Murphy, Anoop N Koshy, William Cameron, Mark Horrigan, Leighton Kearney, Belinda Yeo, Omar Farouque, Matias B Yudi

Journal article  |  2020  |  CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

BACKGROUND: A history of cancer is incorporated into the surgical risk assessment of patients undergoing surgical aortic valve rep..